| Treatment group (n, %) | Control group (n, %) | P value |
---|---|---|---|
Age, years | Â | Â | Â |
Mean ± SD | 6.73 ± 2.12 | 5.72 ± 1.97 | 0.249 |
 > 6 years | 8 (57%) | 5 (50%) |  |
 ≤ 6 years | 6 (43%) | 5 (50%) |  |
Sex | Â | Â | 1.000 |
Male | 10 (71%) | 7 (70%) | Â |
Female | 4 (29%) | 3 (30%) | Â |
Body weight (kg) | 18.82 ± 4.13 | 22.10 ± 7.62 | 0.187 |
GMFCS | Â | Â | 0.783 |
II | 3(21%) | 3(30%) | Â |
III | 4(29%) | 3(30%) | Â |
IV | 5(36%) | 4(40%) | Â |
V | 2(14%) | 1(10%) | Â |
MACS | Â | Â | 0.162 |
II | 5(36%) | 6(60%) | Â |
III | 3(21%) | 1(10%) | Â |
IV | 4(29%) | 1(10%) | Â |
V | 2(14%) | 2(20%) | Â |